CENTRAL PRECOCIOUS PUBERTY
Clinical trials for CENTRAL PRECOCIOUS PUBERTY explained in plain language.
Never miss a new study
Get alerted when new CENTRAL PRECOCIOUS PUBERTY trials appear
Sign up with your email to follow new studies for CENTRAL PRECOCIOUS PUBERTY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Once-a-year shot could halt early puberty in kids
Disease control OngoingThis study tests a yearly injection called Debio 4326 in 56 children with central precocious puberty, a condition where puberty starts too early (before age 8 in girls, 9 in boys). The goal is to see if it can safely suppress puberty hormones back to childhood levels for a full y…
Matched conditions: CENTRAL PRECOCIOUS PUBERTY
Phase: PHASE3 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Hormone blocker aims to pause early puberty in children
Disease control OngoingThis trial tests a long-acting injection of leuprolide acetate in children with central precocious puberty, a condition where puberty starts too early. The goal is to suppress puberty-related hormones, slowing or stopping early development. The study includes children aged 4 to 9…
Matched conditions: CENTRAL PRECOCIOUS PUBERTY
Phase: PHASE4 • Sponsor: HanAll BioPharma Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC